Holen Sie sich die Stockscreener-App
1.68
2.89%
-0.05
Handel nachbörslich:
1.67
-0.01
-0.60%
Schlusskurs vom Vortag:
$1.73
Offen:
$1.74
24-Stunden-Volumen:
56,670
Relative Volume:
0.22
Marktkapitalisierung:
$9.31M
Einnahmen:
$5.64M
Nettoeinkommen (Verlust:
$-23.88M
KGV:
-3.0545
EPS:
-0.55
Netto-Cashflow:
$-22.36M
1W Leistung:
-13.85%
1M Leistung:
-30.00%
6M Leistung:
-74.50%
1J Leistung:
-74.54%
1-Tages-Spanne:
$1.66
$1.76
1-Wochen-Bereich:
$1.66
$2.04
52-Wochen-Spanne:
$1.66
$10.40
Evogene Ltd Stock (EVGN) Company Profile
Vergleichen Sie EVGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| EVGN | 1.68 | 9.31M | 5.64M | -23.88M | -22.36M | -0.55 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Evogene Ltd Stock (EVGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-10-08 | Eingeleitet | ROTH Capital | Buy |
| 2021-07-29 | Eingeleitet | Aegis Capital | Buy |
| 2020-12-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2013-12-16 | Eingeleitet | Oppenheimer | Outperform |
Evogene Ltd Aktie (EVGN) Neueste Nachrichten
Evogene stock hits 52-week low at $1.7 amid market challenges - Investing.com
Evogene subsidiary Lavie Bio announces commercial expansion of Yalos treatment - TipRanks
Lavie Bio's Yalos® Achieves 5% Yield Boost in Soybean Trials, Doubles Market Potential | EVGN Stock News - StockTitan
Evogene Schedules Third Quarter 2024 Financial Results Release - Marketscreener.com
Evogene (EVGN) to Report Q3 2024 Results, Hosts Virtual Conference Call Nov 21 | EVGN Stock News - StockTitan
Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design - Krishak Jagat English
Evogene and Google Cloud Partner to Develop AI Foundation Model for Drug Discovery - HIT Consultant
Evogene stock hits 52-week low at $2.13 amid market challenges - Investing.com Australia
Evogene partners with Google Cloud for AI-driven molecule design By Investing.com - Investing.com Australia
Evogene partners with Google Cloud for AI-driven molecule design - Investing.com India
Biomica to Present at Digestive Disease Week (DDW) Conference 20 - GuruFocus.com
Evogene announces collaboration with Google Cloud - MSN
Syngenta and Lavie Bio Announce Partnership to Discover and Deve - GuruFocus.com
Casterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in Kenya - Krishak Jagat English
Evogene Ltd. (NASDAQ:EVGN) Sees Significant Growth in Short Interest - MarketBeat
Evogene (NASDAQ:EVGN) Stock Crosses Below 200-Day Moving AverageShould You Sell? - MarketBeat
StockNews.com Begins Coverage on Evogene (NASDAQ:EVGN) - MarketBeat
Evogene stock hits 52-week low at $2.21 amid market challenges - Investing.com Nigeria
Evogene (NASDAQ:EVGN) Coverage Initiated by Analysts at StockNews.com - MarketBeat
Watershed, Evogene, and BGU to Expand Gene Editing Applications to White Leg Shrimp and Red Swamp Crayfish - ISAAA
Evogene (NASDAQ:EVGN) Shares Pass Below Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Evogene (NASDAQ:EVGN) Research Coverage Started at StockNews.com - MarketBeat
Watershed AC, Evogene and Ben-Gurion University Receive Approval for Second Year Grant to Continue the Collaboration Focused on Improving Crustacean Traits Utilizing Gene Editing Technology - PR Newswire
Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of ‘MicroFermentor’, a Unique Technology that Can Change the Economics of Ag-Biologicals - Krishak Jagat English
Lavie Bio receives grant to advance ag-biologicals tech - World Bio Market Insights
Evogene (NASDAQ:EVGN) Stock Price Crosses Below 200 Day Moving Average of $5.81 - MarketBeat
StockNews.com Initiates Coverage on Evogene (NASDAQ:EVGN) - MarketBeat
Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of 'MicroFermentor', a Unique Technology that Can Change the Economics of Ag-Biologicals - Lelezard
Evogene receives grant from IIA to advance development of ‘MicroFermentor’ - TipRanks
Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of 'MicroFermentor', a Unique Technology that Can Change the Economics of Ag-Biologicals – Company AnnouncementFT.com - Financial Times
Evogene stock hits 52-week low at $2.6 amid market challenges - Investing.com Canada
Casterra Announces Additional $2.2 Million of Purchase Orders to Supply Castor Seeds for New African Territories - GuruFocus.com
Biomica CEO Set to Attend JP Morgan Healthcare Week in San Franc - GuruFocus.com
Casterra Appoints New CEO and Expands Team to Drive Growth and I - GuruFocus.com
A Tale of Resilience: Evolv Technologies Holdings Inc Amid Stock Market Turbulence - The InvestChronicle
Evotec (NASDAQ:EVO) Sees Unusually-High Trading Volume - MarketBeat
Resolute Capital Asset Partners LLC Buys Shares of 200,000 Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) - Defense World
UBS slashes price target on EVgo Inc [EVGO] – find out why. - The DBT News
Biomica Successfully Completes Phase I Trial Enrollment for Micr - GuruFocus.com
328,106 Shares in Evolent Health, Inc. (NYSE:EVH) Acquired by Federated Hermes Inc. - Defense World
EVgo, Inc. Expected to Post Q3 2024 Earnings of ($0.11) Per Share (NYSE:EVGO) - Defense World
Evolus, Inc. (NASDAQ:EOLS) Shares Purchased by Arizona State Retirement System - Defense World
American Century Companies Inc. Reduces Holdings in Evolent Health, Inc. (NYSE:EVH) - Defense World
Arizona State Retirement System Has $78,000 Stock Holdings in Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) - Defense World
EVgo (NYSE:EVGO) Raised to Strong-Buy at Capital One Financial - Defense World
Finanzdaten der Evogene Ltd-Aktie (EVGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):